Quantifying the effect of glucose 6-phosphate dehydrogenase deficiency on glycated hemoglobin values in children and adolescents with type 1 diabetes.
Adolescents
Children
G6PD deficiency
Glycated hemoglobin
Type 1 diabetes
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
27 Mar 2024
27 Mar 2024
Historique:
received:
08
07
2023
accepted:
23
03
2024
medline:
28
3
2024
pubmed:
28
3
2024
entrez:
28
3
2024
Statut:
epublish
Résumé
The primary objectives of the study were (a) to confirm that glucose 6-phosphate dehydrogenase (G6PD) deficiency affects HbA1c values in a sample of children and adolescents with type 1 diabetes (T1D) and (b) to quantify this effect so that a correction can be applied to the HbA1c values found in current clinical practice. The following data were collected: age, sex, G6PD, number of daily capillary blood glucose measurements, 90-day average blood glucose levels prior to the study, HbA1c, and glycated hemoglobin estimated (eA1c) obtained from blood glucose levels. Patients were divided into three groups based on G6PD values: deficient, intermediate, and nondeficient. In each group, a comparison between the average eA1C and HbA1c values was performed. Then, the difference between the eA1c and HbA1c values of each patient and the mean of the differences (MD) of all patients was calculated within the three groups. Finally, a comparison of the MD values between groups was performed. Seventy-four subjects with T1D were studied. Based on the G6PD value, 33 subjects were deficient, 8 were intermediate, and 33 subjects were nondeficient. In deficient patients, the eA1c values were significantly higher than the HbA1c values. In the other two groups, however, there were no differences. The MD values between the three groups were significantly different. In deficient patients, MD values were higher than those in intermediate and in nondeficient patients. No difference was found between intermediate and nondeficient subjects. Our study confirms that G6PD deficiency affects HbA1c values in children and adolescents with T1D, both in deficient subjects and, to a much lesser extent, in intermediate subjects. In deficient subjects, there is an average reduction in HbA1c attributable to enzyme deficiency of 1.3% (14 mmol/mol) and in intermediate subjects of 0.3% (3 mmol/mol).
Identifiants
pubmed: 38538781
doi: 10.1038/s41598-024-57958-3
pii: 10.1038/s41598-024-57958-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7311Informations de copyright
© 2024. The Author(s).
Références
Erlich, H. et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: Analysis of the type 1 diabetes genetics consortium families. Diabetes 57, 1084–1092 (2008).
doi: 10.2337/db07-1331
pubmed: 18252895
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. NEJM 329, 977–986 (1993).
doi: 10.1056/NEJM199309303291401
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: The Diabetes Control and Complications Trial. J. Pediatr. 125, 177–188 (1994).
doi: 10.1016/S0022-3476(94)70190-3
Battelino, T. et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the International Consensus on Time in Range. Diabetes Care https://doi.org/10.2337/dci19-0028 (2019).
doi: 10.2337/dci19-0028
pubmed: 31575640
pmcid: 6973648
De Bock, M. et al. ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes. Pediatr. Diabetes 23, 1270–1276 (2009).
doi: 10.1111/pedi.13455
Luzzatto, L., Ally, M. & Notaro, R. Glucose-6-phosphate dehydrogenase deficiency. Blood 136, 1225–1240 (2020).
doi: 10.1182/blood.2019000944
pubmed: 32702756
Luzzatto, L., Nannelli, C. & Notaro, R. Glucose-6-phosphate dehydrogenase deficiency. Hematol. Oncol. Clin. N. Am. 30, 373–393. https://doi.org/10.1016/j.hoc.2015.11.006 (2016).
doi: 10.1016/j.hoc.2015.11.006
Harcke, S. J., Rizzolo, D. & Harcke, H. T. G6PD deficiency: An update. JAAPA 32, 21–26. https://doi.org/10.1097/01.JAA.0000586304.65429.a7 (2019).
doi: 10.1097/01.JAA.0000586304.65429.a7
pubmed: 31609781
Tanphaichitr, V. S., Hirono, A., Pung-amritt, P., Treesucon, A. & Wanachiwanawin, W. Chronic nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency: Report of two families with novel mutations causing G6PD Bangkok and G6PD Bangkok Noi. Ann. Hematol. 90, 769–775. https://doi.org/10.1007/s00277-010-1153-4 (2011).
doi: 10.1007/s00277-010-1153-4
pubmed: 21302115
Xu, A. et al. Glucose-6-Phosphate dehydrogenase deficiency associated hemolysis in a cohort of new onset type 1 diabetes children in Guangdong province, China. Diabetol. Metab. Syndr. https://doi.org/10.1186/s13098-022-00812-1 (2022).
doi: 10.1186/s13098-022-00812-1
pubmed: 36397109
pmcid: 9669527
Govindarajan, S., Zamir, I., Sunil Bagewadi, S. & Moore, E. Manifestation of glucose-6-phosphate dehydrogenase deficiency in the wake of new-onset type 1 diabetes mellitus: A case report. J. Med. Case Rep. https://doi.org/10.1186/s13256-022-03549-7 (2022).
doi: 10.1186/s13256-022-03549-7
pubmed: 36008815
pmcid: 9414422
Danzig, J. A., Moser, J. T., Belfield, P. & Alter, C. A. Glucose-6-phosphate dehydrogenase deficiency diagnosed in an adolescent with type 1 diabetes mellitus and hemoglobin A1c discordant with blood glucose measurements. J. Pediatr. 158, 849–851 (2011).
doi: 10.1016/j.jpeds.2010.12.012
pubmed: 21232753
Kweka, B. et al. Influence of hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency on diagnosis of diabetes by HbA1c among Tanzanian adults with and without HIV: A cross-sectional study. PLoS ONE https://doi.org/10.1136/bmjdrc-2019-001091 (2020).
doi: 10.1136/bmjdrc-2019-001091
pubmed: 33382828
pmcid: 7775052
Leong, A. et al. Association of G6PD variants with hemoglobin A1c and impact on diabetes diagnosis in East Asian individuals. BMJ Open Diabetes Res. Care https://doi.org/10.1136/bmjdrc-2019-001091 (2020).
doi: 10.1136/bmjdrc-2019-001091
pubmed: 32209585
pmcid: 7103857
Meloni, T., Pacifico, A., Forteleoni, G. & Meloni, G. F. HbA1 levels in diabetic Sardinian patients with or without G6PD deficiency. Diabetes Res. Clin. Pract. 23, 59–61 (1994).
doi: 10.1016/0168-8227(94)90128-7
pubmed: 8013264
Natan, D. M. et al. Translating the A1C assay into estimated average glucose values. Diabetes Care 31, 1473–1478 (2008).
doi: 10.2337/dc08-0545
Pes, G. M., Errigo, A., Bitti, A. & Dore, M. P. Effect of age, period and birth–cohort on the frequency of glucose 6-phosphate dehydrogenase deficiency in Sardinian adults. Ann. Med. 50, 68–73. https://doi.org/10.1080/07853890.2017.1390247 (2018).
doi: 10.1080/07853890.2017.1390247
pubmed: 28985689
Piona, C. et al. Evaluation of HbA1c and glucose management indicator discordance in a population of children and adolescents with type 1 diabetes. Pediatr. Diabetes https://doi.org/10.1111/pedi.13299 (2021).
doi: 10.1111/pedi.13299
pubmed: 34888998
pmcid: 8453947
Shah, V. N., Vigers, T., Pyle, L., Calhoun, P. & Bergenstal, R. M. Discordance between glucose management indicator and glycated hemoglobin in people without diabetes. Diabetes Technol. Ther. https://doi.org/10.1089/dia.2022.0544 (2022).
doi: 10.1089/dia.2022.0544
pubmed: 36399111
pmcid: 9208859
Besser, R. E. J. et al. ISPAD clinical practice consensus guidelines 2022: Stages of type 1 diabetes in children and adolescents. Pediatr. Diabetes https://doi.org/10.1111/pedi.13410 (2022).
doi: 10.1111/pedi.13410
pubmed: 36323590